Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 2.09x as of 2026-10-06T18:00:59.084Z.
Calculation as of: 2026-10-06T18:00:59.084Z.
Quote observation: 2026-10-06T17:59:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d465a3cb364884174ea279f6e96e1b331d3038a7942601b23d7c9becb19c45da
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
2.09x
SECTOR MEDIAN · HEALTHCARE
1.59x
median of 768 covered companies
CURRENT VS SECTOR MEDIAN
+31.45%
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.14B
EV/Assets Ratio
2.09x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
EV/Assets Ratio
3.24x
TTM Avg
4.44x
3Y Avg
3.71x
5Y Avg
3.50x
Market Cap
$1.14B
EV/Assets Ratio
0.59x
TTM Avg
0.79x
3Y Avg
1.35x
5Y Avg
2.11x
Market Cap
$1.14B
EV/Assets Ratio
0.92x
TTM Avg
0.93x
3Y Avg
1.40x
5Y Avg
1.78x
Market Cap
$1.11B
EV/Assets Ratio
4.12x
TTM Avg
2.36x
3Y Avg
1.60x
5Y Avg
1.77x
Market Cap
$1.11B
EV/Assets Ratio
1.55x
TTM Avg
1.82x
3Y Avg
2.21x
5Y Avg
3.31x
Market Cap
$1.15B
EV/Assets Ratio
1.13x
TTM Avg
3.18x
3Y Avg
1.74x
5Y Avg
1.41x
Market Cap
$1.11B
EV/Assets Ratio
2.09x
TTM Avg
2.40x
3Y Avg
2.65x
5Y Avg
5.31x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.14B | 2.09x | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 3.24x | 4.44x | 3.71x | 3.50x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 0.59x | 0.79x | 1.35x | 2.11x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 0.92x | 0.93x | 1.40x | 1.78x |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 4.12x | 2.36x | 1.60x | 1.77x |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | 1.55x | 1.82x | 2.21x | 3.31x |
| Nektar Therapeutics (NKTR)vs › | $1.15B | 1.13x | 3.18x | 1.74x | 1.41x |
| OPKO Health, Inc. (OPK)vs › | $1.11B | 0.66x | 0.56x | 0.56x | 0.64x |
| STAAR Surgical Company (STAA)vs › | $1.11B | 2.09x | 2.40x | 2.65x | 5.31x |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | 5.12x | 6.84x | 6.84x | 6.84x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
